{"id":185791,"name":"LYMPHOMA RESEARCH FOUNDATION","slug":"lymphoma-research-foundation","state":"NY","country":"United States of America","description":"","totalSpending":0,"filings":32,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["TURNER & GOSS LLP"],"lobbyists":["ELIZABETH GOSS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Legislation to improve quality of care for cancer survivors, under development by Representative Debbie Wasserman Schultz","Development of cancer survivorship legislation to be introduced by Representative Wasserman Schultz.","Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H).","Provide information as requested related to cancer survivorship legislation being developed by Representative Wasserman Schultz.","Cancer Survivorship legislation under development by Representative Wasserman Schultz Standards for distribution and use of monoclonal antibodies and antiviral treatments for the immune compromised"]}